The world's first mRNA vaccine has begun its rollout after being produced at unprecedented speed as part of the global effort to end the COVID-19 pandemic. A second one is hot on its heels. The two—one made by Pfizer/BioNTech ...
Dec 11, 2020
0
168
The COVID-related death rate among Americans who received Johnson & Johnson's COVID-19 vaccine was more than double that of people who received other vaccines, new data from the Omicron surge show.
Mar 26, 2022
1
322
Take a vaccine developed in haste? Never again, says Meissa Chebbi, who, like hundreds of other young Swedes suffered debilitating narcolepsy after a mass vaccination campaign against the 2009-2010 swine flu pandemic.
Nov 26, 2020
0
2106
A new study from La Jolla Institute for Immunology (LJI) scientists helps answer the question: how long does immunity against COVID-19 last in vaccinated people?
Sep 14, 2021
3
1233
A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial published today in The ...
Oct 16, 2020
1
524
With around 256 million cases and more than 5 million deaths worldwide, the COVID-19 pandemic has challenged scientists and those in the medical field. Researchers are working to find effective vaccines and therapies, as ...
Nov 25, 2021
0
1096
It is no secret that thousands of laboratories around the world use cells derived from a fetus that was aborted decades ago to develop vital medicines.
Oct 20, 2020
0
25
Most research on immunity to the SARS-CoV-2 virus and COVID-19 vaccine development has focused on antibody responses to the spike protein and other viral surface proteins. But antibodies that recognize the virus's internal ...
Jun 24, 2022
0
154
For some people, the second dose in a COVID-19 vaccination series is causing a stronger reaction and more side effects than the initial dose. That was also true during the clinical trials.
Feb 17, 2021
0
21
New research published in The Lancet shows that an experimental HIV-1 vaccine regimen is well-tolerated and generated comparable and robust immune responses against HIV in healthy adults and rhesus monkeys. Moreover, the ...
Jul 7, 2018
1
1916
